FDA Expands Sacubitril/Valsartan Indication to Embrace Some HFpEF ...Middle East

The newly approved labeling for sacubitril/valsartan (Entresto) is simply for "chronic heart failure" but almost teasingly adds, "the benefits are most clearly evident" at below-normal LVEF. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Expands Sacubitril/Valsartan Indication to Embrace Some HFpEF )

Also on site :

• 1 in custody, no shots fired: Police respond to Gaylord Rockies Resort Center Wednesday
• Tree falls onto I-77; severe weather around Charlotte causes airport ground stoppage, thousands of power outages
• Trump ready to back new Russia sanctions bill – Politico